Breast Cancer Treatment
Dear Royal Berkshire NHS Foundation Trust,
I would like to please request the following information with regards to Breast Cancer Treatment, on behalf of Novartis.
The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many Metastatic/advanced Breast cancer patients were treated with:
• Abemaciclib (Verzenios) + aromatase inhibitor *
• Abemaciclib (Verzenios) + Fulvestrant (Faslodex)
• Alpelisib (Piqray) + Fulvestrant (Faslodex)
• Atezolizumab (Tecentriq)**
• Bevacizumab (Avastin)
• Eribulin (Halaven)
• Everolimus (Afinitor) + Exemestane
• Fulvestrant (Faslodex) as a single agent
• Gemcitabine + paclitaxel
• Herceptin (Trastuzumab) + paclitaxel
• Herceptin (Trastuzumab) as a single agent
• Lapatinib (Tyverb)
• Neratinib (Nerlynx)
• Olaparib (Lynparza)
• Palbociclib (Ibrance) + aromatase inhibitor*
• Palbociclib (Ibrance) + Fulvestrant (Faslodex)
• Pertuzumab (Perjeta) + trastuzumab + docetaxel
• Ribociclib (Kisqali) + aromatase inhibitor*
• Ribociclib (Kisqali) + Fulvestrant (Faslodex)
• Talazoparib (Talzenna)
• Trastuzumab emtansine (Kadcyla)
• Other active systemic anti-cancer therapy **
*aromatase inhibitor eg. Anastrozole, Exemestane or Letrozole
**eg. docetaxel, vinorelbine or capecitabine as a single agent
Q2. For the above patients, how many of these received their first ever dose for each product line?
Sincerely thank you for taking the time to answer these questions.
Yours faithfully,
Ben Holdsworth
Dear Requester,
We acknowledge your enquiry under the Freedom of Information Act. I will
look into your request and respond within 20 working days from receipt of
your request.
Yours sincerely,
Freedom Of Information Team
Royal Berkshire NHS Foundation Trust
Tel: 0118 322 6743/7405
Email: [Royal Berkshire NHS Foundation Trust request email]
══════════════════════════════════════════════════════════════════════════
Dear Ben Holdsworth,
Further to your request please see the Trust's response below.
Kind regards,
FOI and Policy Officer
Royal Berkshire
NHS Foundation Trust
Level 4
Main Entrance, Craven Road
Reading, Berkshire
RG1 5AN
Natasha Tucker
FOI and Policy Officer
Tel: 0118 322 5111
Email: [1][email address]
Web: [2]www.royalberkshire.nhs.uk
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now